FR2769838B1 - Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique - Google Patents

Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique

Info

Publication number
FR2769838B1
FR2769838B1 FR9712951A FR9712951A FR2769838B1 FR 2769838 B1 FR2769838 B1 FR 2769838B1 FR 9712951 A FR9712951 A FR 9712951A FR 9712951 A FR9712951 A FR 9712951A FR 2769838 B1 FR2769838 B1 FR 2769838B1
Authority
FR
France
Prior art keywords
dermatological
preparation
nitrogen derivatives
cosmetological composition
cosmetological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9712951A
Other languages
English (en)
Other versions
FR2769838A1 (fr
Inventor
Gerd Ries
Dominique Castelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roc SA
Original Assignee
Roc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roc SA filed Critical Roc SA
Priority to FR9712951A priority Critical patent/FR2769838B1/fr
Priority to CO98060041A priority patent/CO4970838A1/es
Priority to PCT/IB1998/001617 priority patent/WO1999020271A1/fr
Priority to AU92785/98A priority patent/AU9278598A/en
Publication of FR2769838A1 publication Critical patent/FR2769838A1/fr
Application granted granted Critical
Publication of FR2769838B1 publication Critical patent/FR2769838B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
FR9712951A 1997-10-16 1997-10-16 Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique Expired - Fee Related FR2769838B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9712951A FR2769838B1 (fr) 1997-10-16 1997-10-16 Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique
CO98060041A CO4970838A1 (es) 1997-10-16 1998-10-15 Uso de derivados de azoles para la preparacion de una composicion dermatologica o cosmetologica
PCT/IB1998/001617 WO1999020271A1 (fr) 1997-10-16 1998-10-15 Utilisation de derives d'azole dans le traitement d'inflammations cutanees
AU92785/98A AU9278598A (en) 1997-10-16 1998-10-15 Use of azole derivatives for the treatment of inflammatory skin conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712951A FR2769838B1 (fr) 1997-10-16 1997-10-16 Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique

Publications (2)

Publication Number Publication Date
FR2769838A1 FR2769838A1 (fr) 1999-04-23
FR2769838B1 true FR2769838B1 (fr) 2000-04-07

Family

ID=9512294

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9712951A Expired - Fee Related FR2769838B1 (fr) 1997-10-16 1997-10-16 Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique

Country Status (4)

Country Link
AU (1) AU9278598A (fr)
CO (1) CO4970838A1 (fr)
FR (1) FR2769838B1 (fr)
WO (1) WO1999020271A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938404A1 (de) * 1999-08-13 2001-02-22 Clariant Gmbh Kosmetische Zubereitungen
US20050201965A1 (en) * 2004-03-11 2005-09-15 The Procter & Gamble Company Personal cleansing compositions
EP1765336A4 (fr) 2004-06-25 2010-03-10 Univ Johns Hopkins Inhibiteurs d'angiogenese
US20060142304A1 (en) * 2004-12-27 2006-06-29 Michael Southall Method for treating or preventing pruritic and neurogenic skin disorders
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
EP2906946A1 (fr) 2012-10-09 2015-08-19 The Procter & Gamble Company Procédé d'identification ou d'évaluation de principes actifs bénéfiques, et compositions contenant ces derniers
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
WO2020127059A1 (fr) * 2018-12-17 2020-06-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation de sulconazole en tant qu'inhibiteur de la furine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210840A (en) * 1984-01-18 1987-05-29 Johnson & Johnson Baby Prod Composition comprising synergistic combination of miconazole nitrate and zinc oxide
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
FR2711990B1 (fr) * 1993-11-05 1995-12-08 Exsymol Sa Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
FR2714380B1 (fr) * 1993-12-24 1996-05-24 Bioxytech Utilisation de dérivés 2-mercapto-imidazole substitués en position 4 (ou 5) comme agents antioxydants, leur procédé de préparation et leurs applications en pharmacie, cosmétique ou alimentaire.

Also Published As

Publication number Publication date
WO1999020271A1 (fr) 1999-04-29
CO4970838A1 (es) 2000-11-07
AU9278598A (en) 1999-05-10
FR2769838A1 (fr) 1999-04-23

Similar Documents

Publication Publication Date Title
FR2732594B1 (fr) Utilisation de derives d'acide salicylique pour la depigmentation de la peau
FR2746316B1 (fr) Nouvelles compositions cosmetologiques ou dermatologiques
FR2765801B1 (fr) Utilisation de monoesters d'arbutine comme agent depigmentant
FR2774587B1 (fr) Utilisation d'une microdispersion de cire dans une composition cosmetique ou dermatologique
FR2769837B1 (fr) Composition pour dietetique ou cosmetique a base d'extraits vegetaux
FR2738746B1 (fr) Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
PT754407E (pt) Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
FR2744912B1 (fr) Composition cosmetique pour mousse capillaire
FR2772612B1 (fr) Utilisation de l'acide cinnamique ou de ses derives dans une composition cosmetique raffermissante
FR2754449B1 (fr) Utilisation de derives d'oxazolidinone comme agents anti-penetrants dans une composition cosmetique et/ou dermatologique
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
FR2763953B1 (fr) Derives de 5'-desoxy-cytidine
FR2769838B1 (fr) Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique
FR2765480B1 (fr) Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques
FR2762353B1 (fr) Joint d'angle auto-adhesif pour feuillures
FR2765803B1 (fr) Composition cosmetique ou dermopharmaceutique pour application topique
FR2811998B1 (fr) Utilisation d'heteroxylanes pour la preparation de compositions filmogenes
DE69710305T2 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl
FR2723317B1 (fr) Utilisation d'antagonistes de la neurotensine pour la preparation de medicaments diuretiques
FR2753980B1 (fr) Procede de preparation d'une composition de revetement anti-uv a base de dioxyde de titane
FR2771287B1 (fr) Utilisation de solvants fluores pour la formulation de lotions pour soins capillaires
MA26481A1 (fr) Derives d'arylsecocholadiene
FR2734560B1 (fr) Compose a base d'yttrium ou d'holmium redispersible sous forme d'un sol
FR2758444B1 (fr) Boucles d'oreille
FR2758458B1 (fr) Produits cosmetiques ou dermo-pharmaceutiques respectant l'ecologie cutanee

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080630